Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

RELL1 Activators

The chemical class known as RELL1 Activators encompasses a diverse set of compounds that engage with signaling pathways, which can lead to the activation of the RELL1 protein. These activators do not interact directly with RELL1 but rather initiate a cascade of intracellular events through their action on various molecular targets, ultimately influencing the activity of RELL1. The primary signaling pathways involved include NF-κB and MAPK, which are central to numerous cellular processes, including those governed by the tumor necrosis factor receptor (TNFR) superfamily, to which RELL1 belongs. Modulation of these pathways by the said activators can lead to changes in gene expression, cell survival, differentiation, and immune responses, all of which are domains where RELL1 is likely to play a role.

The chemicals categorized as RELL1 Activators are typically characterized by their ability to modulate the activity of enzymes, receptors, or other proteins that are upstream of RELL1 in its signaling pathways. By altering the function of these upstream molecules, the activators can indirectly affect the status of RELL1. It is important to understand that these compounds operate within a complex network of cellular signaling and are part of a larger mechanism that controls the function of RELL1. The precise mechanisms by which these activators influence RELL1 activity involve intricate interactions with cellular signaling molecules and are subject to regulation by a myriad of other cellular processes. Despite the indirect nature of their action, these compounds are integral to the modulation of RELL1 activity within the cellular environment.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Modulates NF-κB activity, which is a downstream signaling pathway often associated with TNFR activation and could possibly activate RELL1.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Influences the NF-κB pathway through its role as an antioxidant, potentially affecting TNFR-mediated signaling that could possibly activate RELL1.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Affects NF-κB signaling, which could impact TNFR-related pathways and could possibly activate RELL1.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Interacts with multiple signaling pathways, including NF-κB, potentially altering the activity of TNFRs and could possibly activate RELL1.

Aspirin

50-78-2sc-202471
sc-202471A
5 g
50 g
$20.00
$42.00
4
(1)

Inhibits the NF-κB pathway, which could have downstream effects on TNFR signaling and could possibly activate RELL1.

Parthenolide

20554-84-1sc-3523
sc-3523A
50 mg
250 mg
$81.00
$306.00
32
(2)

Targets NF-κB signaling and could modulate TNFR family receptor activities, which could possibly activate RELL1.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can affect NF-κB activity, potentially influencing TNFR-mediated pathways and could possibly activate RELL1.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An inhibitor of the MAPK pathway, which is often activated by TNFRs, and may therefore affect RELL1 and could possibly activate it.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, part of the MAPK pathway, and could indirectly affect TNFR-related signaling and could possibly activate RELL1.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

Inhibits the NF-κB pathway and could modulate TNFR signaling, potentially impacting RELL1 and could possibly activate it.